Sortilin is a key driver of fibrocalcific aortic valve disease Conference

Schlotter, F, Goettsch, C, Rogers, MA et al. (2018). Sortilin is a key driver of fibrocalcific aortic valve disease . EUROPEAN HEART JOURNAL, 39 1057-1057.

cited authors

  • Schlotter, F; Goettsch, C; Rogers, MA; Hutcheson, JD; Blaser, MC; Goto, S; Lee, LH; Delaughter, DM; Merryman, WD; Seidman, JG; Jaffer, FA; Body, SC; Aikawa, M; Singh, SA; Aikawa, E

authors

date/time interval

  • August 25, 2018 -

publication date

  • August 1, 2018

webpage

published in

keywords

  • Cardiac & Cardiovascular Systems
  • Cardiovascular System & Cardiology
  • Life Sciences & Biomedicine
  • Science & Technology

Location

  • Munich, GERMANY

Conference

  • European-Society-of-Cardiology Congress

publisher

  • OXFORD UNIV PRESS

start page

  • 1057

end page

  • 1057

volume

  • 39